Overcoming Mycobacterium tuberculosis through small molecule inhibitors to break down cell wall synthesis
Open Access
- 27 April 2022
- journal article
- review article
- Published by Elsevier in Acta Pharmaceutica Sinica B
- Vol. 12 (8) , 3201-3214
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (31900687, 82073701)
- Natural Science Foundation of Jiangsu Province (SBK2019040713)
- State Key Laboratory of Natural Medicines (SKLNMZZ202013)
This publication has 98 references indexed in Scilit:
- Trisubstituted Imidazoles as Mycobacterium tuberculosis Glutamine Synthetase InhibitorsJournal of Medicinal Chemistry, 2012
- Inhibition of mycolic acid transport across the Mycobacterium tuberculosis plasma membraneNature Chemical Biology, 2012
- Novel inhibitors of Mycobacterium tuberculosis dTDP-6-deoxy-l-lyxo-4-hexulose reductase (RmlD) identified by virtual screeningBioorganic & Medicinal Chemistry Letters, 2011
- Identification of SQ609 as a lead compound from a library of dipiperidinesBioorganic & Medicinal Chemistry Letters, 2011
- Interaction of N-methyl-2-alkenyl-4-quinolones with ATP-dependent MurE ligase of Mycobacterium tuberculosis: antibacterial activity, molecular docking and inhibition kineticsJournal of Antimicrobial Chemotherapy, 2011
- Phosphorylation of Enoyl-Acyl Carrier Protein Reductase InhA Impacts Mycobacterial Growth and SurvivalJournal of Biological Chemistry, 2010
- Identification of triazinoindol-benzimidazolones as nanomolar inhibitors of the Mycobacterium tuberculosis enzyme TDP-6-deoxy-d-xylo-4-hexopyranosid-4-ulose 3,5-epimerase (RmlC)Bioorganic & Medicinal Chemistry, 2009
- High-throughput screening for inhibitors of Mycobacterium tuberculosis H37RvTuberculosis, 2009
- Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan SynthesisScience, 2009
- Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequenceNature, 1998